ES8701174A1 - Un metodo de preparacion de un compuesto de tiadiazina - Google Patents

Un metodo de preparacion de un compuesto de tiadiazina

Info

Publication number
ES8701174A1
ES8701174A1 ES548330A ES548330A ES8701174A1 ES 8701174 A1 ES8701174 A1 ES 8701174A1 ES 548330 A ES548330 A ES 548330A ES 548330 A ES548330 A ES 548330A ES 8701174 A1 ES8701174 A1 ES 8701174A1
Authority
ES
Spain
Prior art keywords
preparation
compound
general formula
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES548330A
Other languages
English (en)
Other versions
ES548330A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Yoshitomi Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical Industries Ltd filed Critical Yoshitomi Pharmaceutical Industries Ltd
Publication of ES8701174A1 publication Critical patent/ES8701174A1/es
Publication of ES548330A0 publication Critical patent/ES548330A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

METODO DE PREPARACION DE COMPUESTOS DE TIADIAZINA Y SUS SALES DE ADICION DE ACIDOS, DE FORMULA GENERAL (I). CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA GENERAL (II) CON UN COMPUESTO DE FORMULA GENERAL (III) EN UN DISOLVENTE ADECUADO ENTRE LA TEMPERATURA AMBIENTE Y EL PUNTO DE EBULLICION DEL DISOLVENTE EMPLEADO, DURANTE VARIAS HORAS. SE USAN POR SU ACTIVIDAD CARDIOTONICA Y VASODILATADORA CORONARIA ASI COMO INHIBIDORES DE LA AGREGACION DE PLAQUETAS.
ES548330A 1984-10-29 1985-10-29 Un metodo de preparacion de un compuesto de tiadiazina Expired ES8701174A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59227300A JPS61106574A (ja) 1984-10-29 1984-10-29 オキサ（またはチア）ジアジン誘導体

Publications (2)

Publication Number Publication Date
ES8701174A1 true ES8701174A1 (es) 1986-11-16
ES548330A0 ES548330A0 (es) 1986-11-16

Family

ID=16858652

Family Applications (1)

Application Number Title Priority Date Filing Date
ES548330A Expired ES8701174A1 (es) 1984-10-29 1985-10-29 Un metodo de preparacion de un compuesto de tiadiazina

Country Status (8)

Country Link
US (1) US4678785A (es)
EP (1) EP0180158B1 (es)
JP (1) JPS61106574A (es)
KR (1) KR880002086B1 (es)
AT (1) ATE37369T1 (es)
CA (1) CA1246065A (es)
DE (1) DE3565104D1 (es)
ES (1) ES8701174A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0226641B1 (en) * 1985-05-25 1989-10-18 Yoshitomi Pharmaceutical Industries, Ltd. Oxodiazine compounds
AU614965B2 (en) * 1987-06-06 1991-09-19 Merck Patent Gesellschaft Mit Beschrankter Haftung Thiadiazinones
EP0303418A3 (en) * 1987-08-11 1990-11-07 Smithkline Beecham Laboratoires Pharmaceutiques Substituted indolones, useful in the treatment of heart or asthmatic diseases
GB8816944D0 (en) * 1988-07-15 1988-08-17 Sobio Lab Compounds
GB8901836D0 (en) * 1989-01-27 1989-03-15 Sobio Lab Compounds
JPH02279685A (ja) * 1989-04-18 1990-11-15 Yoshitomi Pharmaceut Ind Ltd 新規な結晶構造を有するチアジアジン化合物およびその製造法
US5179203A (en) * 1990-07-31 1993-01-12 Yoshitomi Pharmaceutical Industries Ltd. Thiadiazine compound with a novel crystalline form
DE4041074A1 (de) * 1990-12-21 1992-06-25 Merck Patent Gmbh Thiadiazinonderivate
US6703537B1 (en) * 1997-11-15 2004-03-09 The Procter & Gamble Company Absorbent article having improved fecal storage structure

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052442B1 (en) * 1980-11-14 1985-09-11 Imperial Chemical Industries Plc Heterocyclic compounds
CA1199027A (en) * 1981-11-12 1986-01-07 Stuart D. Mills Heterocyclic derivatives of pyridazinone, thiadiazinone, oxadiazinone and triazinone
US4495185A (en) * 1981-11-12 1985-01-22 Imperial Chemical Industries, Plc 1,2,4-Triazin-3(2H) ones

Also Published As

Publication number Publication date
EP0180158A1 (en) 1986-05-07
DE3565104D1 (en) 1988-10-27
JPS61106574A (ja) 1986-05-24
CA1246065A (en) 1988-12-06
EP0180158B1 (en) 1988-09-21
JPH0129190B2 (es) 1989-06-08
KR860003247A (ko) 1986-05-21
ES548330A0 (es) 1986-11-16
KR880002086B1 (ko) 1988-10-15
ATE37369T1 (de) 1988-10-15
US4678785A (en) 1987-07-07

Similar Documents

Publication Publication Date Title
ES8702339A1 (es) Un procedimiento para preparar d, l-(treo) 1 aril-2-acilamido-3-fluor-1-propanol.
ES8503349A1 (es) Un procedimiento para la preparacion de derivados de benzoisotiazol y benzoisoxazol piperazina.
ES8206443A1 (es) Un procedimiento para preparar un derivado de amidina
ES8303382A1 (es) Un procedimiento para la preparacion de derivados del 1,2,5-tiadiazol.
ES8801642A1 (es) Un procedimiento para la preparacion de l,2,4-triazoles
ES8301980A1 (es) Procedimiento para la preparacion de 8-arilalcohil-3-fenil-3-nortropanoles .
ES8306750A1 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
ES8707731A1 (es) Un procedimiento para la preparacion de derivados de oxindol
ES8504653A1 (es) Un procedimiento para preparar nuevos derivados de eteno
ES8607299A1 (es) Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimida- zo(2,1-b)quinazolinil)-oxialquilamidas
ES8301883A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
ES8707723A1 (es) Un procedimiento para la preparacion de derivados de 1,5-benzotiazepina
ES8202000A1 (es) Procedimiento para preparar pirimidil-quinazolinas
ES8106482A1 (es) Un procedimiento para la preparacion de nuevos acidos feni- lalcanoicos
ES8603835A1 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo piridinometoxi sustituido y de sus sales deadicion acidas y cuaternarias
ES8205750A1 (es) Un procedimiento para la preparacion de nuevos derivados de fenetilamina.
ES8601183A1 (es) Procedimiento para preparar derivados de acidos 1-oxido-1, 2-ditiolano-carboxilicos
ES8403436A1 (es) Procedimiento para la preparacion de carbaciclinamidas
ES427433A1 (es) Un procedimiento para preparar un compuesto quimico selec- cionado del grupo que consiste en o-tiocarbamato de nitroi- midazolil-etilo.
ES8600297A1 (es) Procedimiento para preparar derivados de imidazol.
ES8200370A1 (es) Procedimiento para la preparacion de nuevas cefalosporinas
ES8603827A1 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo piperidinopropanolico sustituido y sus sa- les de adicion acidas y amonicas cuaternarias
ES8400084A1 (es) Procedimiento para preparar n-alcoxisulfenicarbamatos.
ES8300722A1 (es) Procedimiento para la preparacion de carbamoiloxiamino-1,4- benzodiazepinas
ES8502992A1 (es) Procedimiento para la preparacion de un (tio)-eter de 2-metil-liserg-8-ilo

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001